期刊文献+

重组新城疫病毒rl-RVG抑制人肺腺癌A549系细胞迁移及相关机制 被引量:3

Recombinant avirulent newcastle disease virus rl-RVG inhibits migration of lung adenocarcinoma A549 and related mechanism
下载PDF
导出
摘要 目的观察表达狂犬病毒糖蛋白的重组新城疫病毒(rl-RVG)对人肺癌细胞系A549的迁移影响,初步探讨其可能的机制。方法重组新城疫病毒rl-RVG直接感染A549细胞为rl-RVG实验组,新城疫病毒La Sota株处理的A549细胞组及未感染病毒的A549细胞组作为对照组。Western blot法检测NDV-HN蛋白及狂犬病毒糖蛋白(RVG),细胞增殖实验测定新城疫病毒使用的最佳作用浓度;划痕实验及Transwell法测A549迁移;Western blot法及免疫荧光法检测E-cadherin,MMP2蛋白表达。结果空白对照组无NDV、rl-RVG表达,rl-RVG仅在感染rl-RVG细胞组有表达,NDV在感染rl-RVG细胞组及感染NDV细胞组皆有表达;与空白对照组相比,rl-RVG及NDV稀释浓度大于5×10-5对细胞的增殖有抑制作用(P<0.05);rl-RVG组迁移的距离及细胞数明显减少(P<0.05)。与空白对照组及NDV感染组相比,rl-RVG组E-cadherin蛋白表达水平上调(P<0.05),MMP2蛋白表达水平减弱(P<0.05)。结论重组新城疫病毒rl-RVG能抑制人肺癌细胞系A549的迁移,并可能通过影响肺腺癌A549上皮细胞-间质转化(EMT)过程中的调控因子E-cadherin,MMP2蛋白而对细胞迁移而作用。 Objective Observe the effects of rl-RVG on migration of lung adenocarcinoma A549cells, preliminarily explore potential mechanism. Methods The group infected with the rl-RVG was experimental group, The group infected with NDV and the group not infected with virous were control groups. The experimental detected for the ex- pressions of RVG and NDV-HN proteins by Western blot. Cell growth experiment determined the best active concen- trations of newcastle disease virus and rl-RVG; Observe the effects of rl-RVG and NDV on migration of lung adeno- carcinoma A549 cells by scratch assay and Transwell method. The expression of E-cadherin and MMP2 was ob- served by Western blot and immunofluorescence. The LaSota strain of NDV was used as control group and PBS was the blank control. Results Neither RVG nor NDV proteins didn't expressed in blank control group. RVG proteinexpressed in rl-RVG group and NDV protein expressed inhibited in rl-RVG group and NDV group more signifi in both rl-RVG group and NDV group. Cell proliferation was cantly as compared with the blank control group(P 〈.0. 05 ). After infected with rl-RVG, migration distance and number of cells significantly reduced ( P 〈 0. 05 ). After A549 cells were infected with rl-RVG, the expression of E-cadherin was enhanced (P 〈 0. 05 )and the expression of MMP2 was decreased as compared with the blank control group and NDV group ( P 〈 0. 05 ). Conclusions Recom- binant avirulent newcastle disease virus can inhibit the migration of A549 cells in vitro, which may be attributed to regulatory factors of E-eadherin and MMP2 in the procession of epithelial mesenchymal transition EMT.
出处 《基础医学与临床》 CSCD 2015年第4期508-513,共6页 Basic and Clinical Medicine
基金 镇江市社会发展基金(2013041)
关键词 重组新城疫病毒RVG 肺癌 迁移 上皮细胞-间质转化 rl-RVG lung cancer migration epithelial mesenchymal transition
  • 相关文献

参考文献15

  • 1Janke M, Peeters B,de Leeuw 0, et al. Recombinant New-castle disease virus ( NDV) with inserted gene coding forGM-CSF as a new vector for cancer immunogene therapy[J]. Gene Therapy, 2007, 14: 1639-1649.
  • 2Ge J, Wang X, Tao L, et al. Newcastle disease virus-vec-tored rabies vaccine is safe, highly immunogenic, and pro-vides long-lasting protection in dogs and cats. [ J] ? J Virol,2011, 85: 8241-8252.
  • 3严玉兰,梁冰,张金,贾丽娟,刘洋,张杰.rL-RVG体外抑制肺癌细胞增殖并促进其凋亡[J].细胞与分子免疫学杂志,2014,30(5):449-452. 被引量:2
  • 4Kim YJ,Lee SA,Myung SC,ei al. Radicicol,an inhibitor ofHsp90,enhances TRAIL-induced apoptosis in human epi-thelial ovarian carcinoma cells by promoting activation ofapoptosis-related proteins [ J ]. Mol Cell Biochem, 2012,359: 33-43.
  • 5Pecora AL, Rizvi N, Cohen GI, et al. Phase I trial of intra-venous administration of PV701, an oncolytic virus,in pa-tients with advanced solid cancers. [ J ]. J Clin Oncol,2002, 20: 2251-2266.
  • 6Freeman Al, Zakay-Rones Z,Gomori JM, et al. Phase I/IItrial of intravenous NDV-HUJ oncolytic virus in recurrentglioblastoma multiforme. [J]. Mol Ther, 2006,13:221-228.
  • 7Fu F, Zhao M,Yang YJ’et al. Antiproliferative effect ofnewcastle disease virus strain D90 on human lung cancercell line A549[ J]. Oncol Res, 2011,19: 323-333.
  • 8Phuangsab A,Lorence RM, Reichard KW9et al. Newcastledisease virus therapy of human tumor xenografts : antitumoreffects of local or systemic administration. [ J ]. CancerLett, 2001,172: 27-36.
  • 9Elankumaran S,Rockemann D,Samal SK. Newcastle diseasevirus exerts oncolysis by both intrinsic and extrinsiccaspasE-dependent pathways of cell death [ J ]. J Virol,2006,80: 7522-7534.
  • 10Hrabak A,Csuka I,Bajor T,et al. The cytotoxic anti-tumoreffect of MTH-68 /H, live attenuated Newcastle diseasevirus is mediated by the induction of nitric oxide synthesisin rat peritoneal macrophages in vitro [ J ]. Cancer Lett,2006,231: 279-289.

二级参考文献15

  • 1徐兰,郭增柱,张永振,熊成龙,Zhen F.Fu.狂犬病毒糖蛋白研究进展[J].中国人兽共患病学报,2006,22(9):876-879. 被引量:22
  • 2Cassel WA, Garrett RE. Newcastle disease virus as an antineoplastic agent[ J]. Cancer, 1965, 18 : 863 - 868.
  • 3Lam HY, Yeap SK, Rasoli M, et al. Safety and clinical usage of new- castle disease virus in cancer therapy [ J/OL]. J Biomed Biotechnol, 2011, 2011 : 718710.
  • 4Prehaud C, Lay S, Dietzschold B, et al. Glycoprotein of nanpathogcnic rabies viruses is a key determinant of human cell apoptosis [ J ]. J Virol, 2003, 77(19) : 10537 - 10547.
  • 5Ge J, Wang X, Tao L, et al. Newcastle disease virus-vectored rabies vaccine is safe, highly i mmunogenic, and provides long-lasting protection in dogs and cats[J]. J Virul, 2011, 85 (16) : 8241 - 8252.
  • 6Zamarin D,.Palese P. Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions [ J ]. Futm Microbiol, 2012, 7(3) : 347 -367.
  • 7Ghrici M, E1 Zowalaty M, Omar AR, et al. Induction of apoptosis in MCF-7 cells by the hemagglutinin-neuraminidase glycoprotein of Newcastle disease virus Malaysian strain AF2240 [ J ]. Oncol Rep, 2013, 30(3) : 1035 -1044.
  • 8Elankumaran S, Chavan V, Qiao D, et al. Type I interferon-sensitive recombinant newcastle disease virus for oncolytic virotherapy [ J ]. J Virol, 2010, 84(8) : 3835 -3844.
  • 9Janke M, Peeters B, de Leeuw O, et al. Recombinant newcastle disease virus (NDV) with inserted gene coding for GM-CSF as a new vector for cancer immunogene therapy [ J ]. Gene Ther, 2007, 14 (23) : 1639 -1649.
  • 10Shobana R, Samal SK, Elankumaran S. Prostate-specific antigen- retargeted recombinant newcastle disease virus for prostate cancer virotherapy[ J]. J Virol, 2013, 87(7) : 3792 -3800.

共引文献1

同被引文献14

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部